Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trump Tries To Shame A Defiant Pfizer On Drug Pricing

Executive Summary

President Trump called out Pfizer’s recent price increases on Twitter July 9. Pfizer was one of only four companies that took a second round of price increases in 2018, according to analysts at Morgan Stanley. CEO Read has long defended the industry's pricing practices, even as public criticism of the high drug prices has grown. 

Advertisement

Related Content

Amgen Drops Repatha List Price 60% To Cut Medicare Co-Pays And Boost Use
Amgen Drops Repatha List Price 60% To Cut Medicare Co-Pays And Boost Use
Pfizer's CEO Is Bullish On Rebate Changes That Could Power New Launches
Merck's New Pricing Pledge Shows Style Over Substance
Novartis Puts A Halt To Drug Price Increases While Awaiting More On Trump's Blueprint
Trump Expecting Rx Price Reduction Announcements In Two Weeks
Trump Drug Pricing Plan Includes Part D Surprises, Challenges PBM Business Model
Pfizer Not Making Pricing Changes, Sees Ways To Work With Trump
Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan
Pharma CEOs Tackle A Tough Question: “Why Don’t People Like You?”

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123380

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel